Skip to main content
Top
Published in: BMC Endocrine Disorders 1/2014

Open Access 01-12-2014 | Case report

Takotsubo cardiomyopathy and transient thyrotoxicosis during combination therapy with interferon-alpha and ribavirin for chronic hepatitis C

Authors: Carmen Sorina Martin, Luminita Nicoleta Ionescu, Carmen Gabriela Barbu, Anca Elena Sirbu, Ioana Maria Lambrescu, Ioana Smarandita Lacau, Doina Ruxandra Dimulescu, Simona Vasilica Fica

Published in: BMC Endocrine Disorders | Issue 1/2014

Login to get access

Abstract

Background

Thyroid dysfunction is a common complication of chronic hepatitis C (CHC) and its therapy. Takotsubo cardiomyopathy (TCM) is a multifactorial, stress related cardiomyopathy, rarely reported in association with thyrotoxicosis. Simultaneous occurrence of TCM and thyrotoxicosis due to hepatitis C and its treatment has never been reported.

Case presentation

A 47-year-old woman was admitted for acute chest pain, dyspnea, palpitations and diaphoresis. She had been diagnosed with CHC and had undergone 7 months of IFNα and Ribavirin therapy. At admission electrocardiogram (ECG) showed ST segment elevation, negative T waves and troponin was elevated suggesting ST segment elevation myocardial infarction (STEMI). Echocardiography demonstrated left ventricular apical akinesia and ballooning, with a left ventricular ejection fraction (LVEF) of 35%. Contrast angiography showed normal epicardial coronaries, yet a ventriculogram revealed left ventricular apical ballooning, consistent with TCM. Cardiac MRI showed left ventricle apical ballooning and no late enhancement suggesting the absence of any edema, scar or fibrosis in the left myocardium. She was diagnosed with non-autoimmune destructive thyroiditis: TSH=0.001 mU/L, free T4=2.41 ng/dl, total T3=199 ng/dl and negative thyroid antibodies. The thyroid ultrasonography showed a diffuse small goiter, no nodules and normal vascularization of the parenchyma. Following supportive treatment she experienced a complete recovery after a few weeks and she successfully completed her antiviral treatment, with no thyroid or cardiovascular dysfunction ever since. In patients treated with IFNα for CHC, the prevalence of thyroid dysfunction varies between 2.5–45.3% of cases. TCM is a stress related cardiomyopathy characterized by elevated cardiac enzymes, normal coronary angiography and an acute, transient, left ventricular apical dysfunction that mimics myocardial infarction. Most of the patients survive the initial acute event, typically recover normal ventricular function within one to four weeks and have a favorable outcome, as was the case with our patient. Thyrotoxicosis induced stress cardiomyopathy is rare and has been mostly reported in association with Graves’ disease, thyroid storm, thyrotoxicosis factitia or following radioiodine therapy for toxic multinodular goiter.

Conclusion

Routine thyroid screening should be done in patients receiving IFN-alpha and Ribavirin for CHC and thyrotoxicosis should be considered as a possible and treatable underlying cause of TCM.
Appendix
Available only for authorised users
Literature
2.
go back to reference Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Gonçales FL, Häussinger D, Diago M, Carosi G, Dhumeaux D, Craxi A, Lin A, Hoffman J, Yu J: Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med. 2002, 347 (13): 975-982. 10.1056/NEJMoa020047.CrossRefPubMed Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Gonçales FL, Häussinger D, Diago M, Carosi G, Dhumeaux D, Craxi A, Lin A, Hoffman J, Yu J: Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med. 2002, 347 (13): 975-982. 10.1056/NEJMoa020047.CrossRefPubMed
3.
go back to reference Carella C, Mazziotti G, Morisco F, Manganella G, Rotondi M, Tuccillo C, Sorvillo F, Caporaso N, Amato G: Long-term outcome of interferon-Alfa induced thyroid autoimmunity and prognostic influence of thyroid autoantibody pattern at the end of treatment. J Clin Endocrinol Metab. 2001, 86 (5): 1925-1929.PubMed Carella C, Mazziotti G, Morisco F, Manganella G, Rotondi M, Tuccillo C, Sorvillo F, Caporaso N, Amato G: Long-term outcome of interferon-Alfa induced thyroid autoimmunity and prognostic influence of thyroid autoantibody pattern at the end of treatment. J Clin Endocrinol Metab. 2001, 86 (5): 1925-1929.PubMed
4.
go back to reference Tomer Y, Peters JJ, Menconi F: Interferon induced thyroiditis. Best Pract Res Clin Endocrinol Metab. 2009, 23 (6): 703-712. 10.1016/j.beem.2009.07.004.CrossRefPubMedPubMedCentral Tomer Y, Peters JJ, Menconi F: Interferon induced thyroiditis. Best Pract Res Clin Endocrinol Metab. 2009, 23 (6): 703-712. 10.1016/j.beem.2009.07.004.CrossRefPubMedPubMedCentral
5.
go back to reference Koh LK, Greenspan FS, Yeo PP: Interferon-alpha induced thyroid dysfunction: three clinical presentations and a review of the literature. Thyroid. 1997, 7: 891-896. 10.1089/thy.1997.7.891.CrossRefPubMed Koh LK, Greenspan FS, Yeo PP: Interferon-alpha induced thyroid dysfunction: three clinical presentations and a review of the literature. Thyroid. 1997, 7: 891-896. 10.1089/thy.1997.7.891.CrossRefPubMed
6.
go back to reference Miyazaki S, Kamiishi T, Hosokawa N, Komura M, Konagai H, Sagai H, Takamoto T: Reversible left ventricular dysfunction “takotsubo” cardiomyopathy associated with hyperthyroidism. Jpn Heart J. 2004, 45 (5): 889-894. 10.1536/jhj.45.889.CrossRefPubMed Miyazaki S, Kamiishi T, Hosokawa N, Komura M, Konagai H, Sagai H, Takamoto T: Reversible left ventricular dysfunction “takotsubo” cardiomyopathy associated with hyperthyroidism. Jpn Heart J. 2004, 45 (5): 889-894. 10.1536/jhj.45.889.CrossRefPubMed
7.
go back to reference Kawai S, Kitabatake A, Tomoike H: Guidelines for diagnosis of takotsubo (ampulla) cardiomyopathy. Circ J. 2007, 71 (6): 990-992. 10.1253/circj.71.990.CrossRefPubMed Kawai S, Kitabatake A, Tomoike H: Guidelines for diagnosis of takotsubo (ampulla) cardiomyopathy. Circ J. 2007, 71 (6): 990-992. 10.1253/circj.71.990.CrossRefPubMed
8.
go back to reference Antonelli A, Ferri C, Pampana A, Fallahi P, Nesti C, Pasquini M, Marchi S, Ferrannini E: Thyroid disorders in chronic hepatitis C. Am J Med. 2004, 117 (1): 10-13. 10.1016/j.amjmed.2004.01.023.CrossRefPubMed Antonelli A, Ferri C, Pampana A, Fallahi P, Nesti C, Pasquini M, Marchi S, Ferrannini E: Thyroid disorders in chronic hepatitis C. Am J Med. 2004, 117 (1): 10-13. 10.1016/j.amjmed.2004.01.023.CrossRefPubMed
9.
go back to reference Vezali E, Elefsiniotis I, Mihas C, Konstantinou E, Saroglou G: Thyroid dysfunction in patients with chronic hepatitis C: virus- or therapy-related?. J Gastroenterol Hepatol. 2009, 24 (6): 1024-1029. 10.1111/j.1440-1746.2009.05812.x.CrossRefPubMed Vezali E, Elefsiniotis I, Mihas C, Konstantinou E, Saroglou G: Thyroid dysfunction in patients with chronic hepatitis C: virus- or therapy-related?. J Gastroenterol Hepatol. 2009, 24 (6): 1024-1029. 10.1111/j.1440-1746.2009.05812.x.CrossRefPubMed
10.
go back to reference Dalgard O, Bjøro K, Hellum K, Myrvang B, Bjøro T, Haug E, Bel H: Thyroid dysfunction during treatment of chronic hepatitis C with interferon alpha: no association with either interferon dosage or efficacy of therapy. J Intern Med. 2002, 251: 400-406. 10.1046/j.1365-2796.2002.00974.x.CrossRefPubMed Dalgard O, Bjøro K, Hellum K, Myrvang B, Bjøro T, Haug E, Bel H: Thyroid dysfunction during treatment of chronic hepatitis C with interferon alpha: no association with either interferon dosage or efficacy of therapy. J Intern Med. 2002, 251: 400-406. 10.1046/j.1365-2796.2002.00974.x.CrossRefPubMed
11.
go back to reference Eliades M, El-Maouche D, Choudhary C, Zinsmeister B, Burman KD: Takotsubo cardiomyopathy associated with thyrotoxicosis: a case report and review of the literature. Thyroid. 2013, Not available-, ahead of print. doi:10.1089/thy.2012.0384 Eliades M, El-Maouche D, Choudhary C, Zinsmeister B, Burman KD: Takotsubo cardiomyopathy associated with thyrotoxicosis: a case report and review of the literature. Thyroid. 2013, Not available-, ahead of print. doi:10.1089/thy.2012.0384
12.
go back to reference Micallef T, Gruppetta M, Cassar A, Fava S: Takotsubo cardiomyopathy and severe hypothyroidism. J Cardiovasc Med (Hagerstown). 2011, 12 (11): 824-827. 10.2459/JCM.0b013e3283403454.CrossRef Micallef T, Gruppetta M, Cassar A, Fava S: Takotsubo cardiomyopathy and severe hypothyroidism. J Cardiovasc Med (Hagerstown). 2011, 12 (11): 824-827. 10.2459/JCM.0b013e3283403454.CrossRef
13.
go back to reference Al-Salameh A, Allain J, Meimoun P, Benali T, Desailloud R: Takotsubo cardiomyopathy could occur in patients with apathetic hyperthyroidism. Thyroid. 2013, -Not available-, ahead of print. doi:10.1089/thy.2013.0354 Al-Salameh A, Allain J, Meimoun P, Benali T, Desailloud R: Takotsubo cardiomyopathy could occur in patients with apathetic hyperthyroidism. Thyroid. 2013, -Not available-, ahead of print. doi:10.1089/thy.2013.0354
14.
go back to reference Dahdouh Z, Roule V, Bignon M, Grollier G: Recurrent tako tsubo related to subclinical hyperthyroidism. Rev Esp Cardiol. 2011, 64 (11): 1069-1071. 10.1016/j.recesp.2011.01.003.CrossRefPubMed Dahdouh Z, Roule V, Bignon M, Grollier G: Recurrent tako tsubo related to subclinical hyperthyroidism. Rev Esp Cardiol. 2011, 64 (11): 1069-1071. 10.1016/j.recesp.2011.01.003.CrossRefPubMed
15.
go back to reference Alidjan F, Ezzhati M, Bruggeling W, van Guldener C: Takotsubo cardiomyopathy precipitated by thyrotoxicosis. Thyroid. 2010, 20 (12): 1427-1428. 10.1089/thy.2009.0444.CrossRefPubMed Alidjan F, Ezzhati M, Bruggeling W, van Guldener C: Takotsubo cardiomyopathy precipitated by thyrotoxicosis. Thyroid. 2010, 20 (12): 1427-1428. 10.1089/thy.2009.0444.CrossRefPubMed
16.
go back to reference Hutchings DC, Adlam D, Ferreira V, Karamitsos TD, Channon KM: Takotsubo cardiomyopathy in association with endogenous and exogenous thyrotoxicosis. QJM. 2011, 104 (5): 433-435. 10.1093/qjmed/hcq099.CrossRefPubMed Hutchings DC, Adlam D, Ferreira V, Karamitsos TD, Channon KM: Takotsubo cardiomyopathy in association with endogenous and exogenous thyrotoxicosis. QJM. 2011, 104 (5): 433-435. 10.1093/qjmed/hcq099.CrossRefPubMed
17.
go back to reference Sarullo FM, Americo L, Accardo S, Cicero S, Schicchi R, Schirò M, Castello A: Tako-tsubo cardiomyopathy observed in a patient with sepsis and transient hyperthyroidism. Monaldi Arch Chest Dis. 2009, 72 (1): 33-36.PubMed Sarullo FM, Americo L, Accardo S, Cicero S, Schicchi R, Schirò M, Castello A: Tako-tsubo cardiomyopathy observed in a patient with sepsis and transient hyperthyroidism. Monaldi Arch Chest Dis. 2009, 72 (1): 33-36.PubMed
18.
go back to reference Radhakrishnan A, Granato JE: An association between takotsubo cardiomyopathy and thyroid storm. Postgrad Med. 2009, 121 (3): 126-130. 10.3810/pgm.2009.05.2012.CrossRefPubMed Radhakrishnan A, Granato JE: An association between takotsubo cardiomyopathy and thyroid storm. Postgrad Med. 2009, 121 (3): 126-130. 10.3810/pgm.2009.05.2012.CrossRefPubMed
19.
go back to reference Hatzakorzian R, Bui H, Schricker T, Backman SB: Broken heart syndrome triggered by an obstructive goiter not associated with thyrotoxicosis. Can J Anaesth. 2013, 60 (8): 808-812. 10.1007/s12630-013-9964-0.CrossRefPubMed Hatzakorzian R, Bui H, Schricker T, Backman SB: Broken heart syndrome triggered by an obstructive goiter not associated with thyrotoxicosis. Can J Anaesth. 2013, 60 (8): 808-812. 10.1007/s12630-013-9964-0.CrossRefPubMed
20.
go back to reference van de Donk NW, America YG, Zelissen PM, Hamer BJ: Takotsubo cardiomyopathy following radioiodine therapy for toxic multinodular goitre. Neth J Med. 2009, 67 (10): 350-352.PubMed van de Donk NW, America YG, Zelissen PM, Hamer BJ: Takotsubo cardiomyopathy following radioiodine therapy for toxic multinodular goitre. Neth J Med. 2009, 67 (10): 350-352.PubMed
21.
go back to reference Gundara JS, Lee JC, Ip J, Sidhu SB: Takotsubo cardiomyopathy complicating thyroidectomy for Graves’ disease. Thyroid. 2012, 22 (9): 975-976. 10.1089/thy.2012.0101.CrossRefPubMed Gundara JS, Lee JC, Ip J, Sidhu SB: Takotsubo cardiomyopathy complicating thyroidectomy for Graves’ disease. Thyroid. 2012, 22 (9): 975-976. 10.1089/thy.2012.0101.CrossRefPubMed
22.
go back to reference Kurowski V, Kaiser A, von Hof K, Killermann DP, Mayer B, Hartmann F, Schunkert H, Radke PW: Apical and midventricular transient left ventricular dysfunction syndrome (tako-tsubo cardiomyopathy): frequency, mechanisms, and prognosis. Chest. 2007, 132 (3): 809-816. 10.1378/chest.07-0608.CrossRefPubMed Kurowski V, Kaiser A, von Hof K, Killermann DP, Mayer B, Hartmann F, Schunkert H, Radke PW: Apical and midventricular transient left ventricular dysfunction syndrome (tako-tsubo cardiomyopathy): frequency, mechanisms, and prognosis. Chest. 2007, 132 (3): 809-816. 10.1378/chest.07-0608.CrossRefPubMed
23.
go back to reference Pilgrim TM, Wyss TR: Takotsubo cardiomyopathy or transient left ventricular apical ballooning syndrome: a systematic review. Int J Cardiol. 2008, 124 (3): 283-292. 10.1016/j.ijcard.2007.07.002.CrossRefPubMed Pilgrim TM, Wyss TR: Takotsubo cardiomyopathy or transient left ventricular apical ballooning syndrome: a systematic review. Int J Cardiol. 2008, 124 (3): 283-292. 10.1016/j.ijcard.2007.07.002.CrossRefPubMed
24.
go back to reference Eitel I, von Knobelsdorff-Brenkenhoff F, Bernhardt P, Carbone I, Muellerleile K, Aldrovandi A, Francone M, Desch S, Gutberlet M, Strohm O, Schuler G, Schulz-Menger J, Thiele H, Friedrich MG: Clinical characteristics and cardiovascular magnetic resonance findings in stress (takotsubo) cardiomyopathy. JAMA. 2011, 306 (3): 277-286.CrossRefPubMed Eitel I, von Knobelsdorff-Brenkenhoff F, Bernhardt P, Carbone I, Muellerleile K, Aldrovandi A, Francone M, Desch S, Gutberlet M, Strohm O, Schuler G, Schulz-Menger J, Thiele H, Friedrich MG: Clinical characteristics and cardiovascular magnetic resonance findings in stress (takotsubo) cardiomyopathy. JAMA. 2011, 306 (3): 277-286.CrossRefPubMed
25.
go back to reference Caforio AL, Tona F, Vinci A, Calabrese F, Ramondo A, Cacciavillani L, Corbetti F, Leoni L, Thiene G, Iliceto S, Angelini A: Acute biopsy-proven lymphocytic myocarditis mimicking takotsubo cardiomyopathy. Eur J Heart Fail. 2009, 11 (4): 428-431. 10.1093/eurjhf/hfp008.CrossRefPubMed Caforio AL, Tona F, Vinci A, Calabrese F, Ramondo A, Cacciavillani L, Corbetti F, Leoni L, Thiene G, Iliceto S, Angelini A: Acute biopsy-proven lymphocytic myocarditis mimicking takotsubo cardiomyopathy. Eur J Heart Fail. 2009, 11 (4): 428-431. 10.1093/eurjhf/hfp008.CrossRefPubMed
26.
go back to reference Gianni M, Dentali F, Grandi AM, Sumner G, Hiralal R, Lonn E: Apical ballooning syndrome or tako-tsubo cardiomyopathy: a systematic review. Eur Heart J. 2006, 27: 1523-1529. 10.1093/eurheartj/ehl032.CrossRefPubMed Gianni M, Dentali F, Grandi AM, Sumner G, Hiralal R, Lonn E: Apical ballooning syndrome or tako-tsubo cardiomyopathy: a systematic review. Eur Heart J. 2006, 27: 1523-1529. 10.1093/eurheartj/ehl032.CrossRefPubMed
27.
go back to reference Prasad A, Lerman A, Rihal CS: Apical ballooning syndrome (tako-tsubo or stress cardiomyopathy): a mimic of acute myocardial infarction. Am Heart J. 2008, 155: 408-417. 10.1016/j.ahj.2007.11.008.CrossRefPubMed Prasad A, Lerman A, Rihal CS: Apical ballooning syndrome (tako-tsubo or stress cardiomyopathy): a mimic of acute myocardial infarction. Am Heart J. 2008, 155: 408-417. 10.1016/j.ahj.2007.11.008.CrossRefPubMed
28.
go back to reference Nef HM, Möllmann H, Kostin S, Troidl C, Voss S, Weber M, Dill T, Rolf A, Brandt R, Hamm CW, Elsässer A: Tako-Tsubo cardiomyopathy: intraindividual structural analysis in the acute phase and after functional recovery. Eur Heart J. 2007, 28: 2456-2464. 10.1093/eurheartj/ehl570.CrossRefPubMed Nef HM, Möllmann H, Kostin S, Troidl C, Voss S, Weber M, Dill T, Rolf A, Brandt R, Hamm CW, Elsässer A: Tako-Tsubo cardiomyopathy: intraindividual structural analysis in the acute phase and after functional recovery. Eur Heart J. 2007, 28: 2456-2464. 10.1093/eurheartj/ehl570.CrossRefPubMed
29.
go back to reference Nef HM, Mo¨llmann H, Akashi YJ, Hamm CW: Mechanisms of stress (takotsubo) cardiomyopathy. Nat Rev Cardiol. 2010, 7: 187-193. 10.1038/nrcardio.2010.16.CrossRefPubMed Nef HM, Mo¨llmann H, Akashi YJ, Hamm CW: Mechanisms of stress (takotsubo) cardiomyopathy. Nat Rev Cardiol. 2010, 7: 187-193. 10.1038/nrcardio.2010.16.CrossRefPubMed
30.
go back to reference Khallafi H, Chacko V, Varveralis N, Elmi F: Broken heart syndrome: catecholamine surge or aborted myocardial infarction?. J Invasive Cardiol. 2008, 20E: 9-13. Khallafi H, Chacko V, Varveralis N, Elmi F: Broken heart syndrome: catecholamine surge or aborted myocardial infarction?. J Invasive Cardiol. 2008, 20E: 9-13.
31.
go back to reference Sharkey SW, Lesser JR, Menon M, Parpart M, Maron MS, Maron BJ: Spectrum and significance of electrocardiographic patterns, troponin levels, and thrombolysis in myocardial infarction frame count in patients with stress (tako-tsubo) cardiomyopathy and comparison to those in patients with ST-elevation anterior wall myocardial infarction. Am J Cardiol. 2008, 101 (12): 1723-1728. 10.1016/j.amjcard.2008.02.062.CrossRefPubMed Sharkey SW, Lesser JR, Menon M, Parpart M, Maron MS, Maron BJ: Spectrum and significance of electrocardiographic patterns, troponin levels, and thrombolysis in myocardial infarction frame count in patients with stress (tako-tsubo) cardiomyopathy and comparison to those in patients with ST-elevation anterior wall myocardial infarction. Am J Cardiol. 2008, 101 (12): 1723-1728. 10.1016/j.amjcard.2008.02.062.CrossRefPubMed
32.
go back to reference Kassim TA, Clarke DD, Mai VQ, Clyde PW, Mohamed Shakir KM: Catecholamine-induced cardiomyopathy. Endocr Pract. 2008, 14 (9): 1137-1149. 10.4158/EP.14.9.1137.CrossRefPubMed Kassim TA, Clarke DD, Mai VQ, Clyde PW, Mohamed Shakir KM: Catecholamine-induced cardiomyopathy. Endocr Pract. 2008, 14 (9): 1137-1149. 10.4158/EP.14.9.1137.CrossRefPubMed
33.
go back to reference Masani ND, Northridge DB, Hall RJ: Severe coronary vasospasm associated with hyperthyroidism causing myocardial infarction. Br Heart J. 1995, 74: 700-771. 10.1136/hrt.74.6.700.CrossRefPubMedPubMedCentral Masani ND, Northridge DB, Hall RJ: Severe coronary vasospasm associated with hyperthyroidism causing myocardial infarction. Br Heart J. 1995, 74: 700-771. 10.1136/hrt.74.6.700.CrossRefPubMedPubMedCentral
34.
go back to reference Klein I, Ojamaa K: Thyroid hormone and the cardiovascular system. N Engl J Med. 2001, 344 (7): 501-509. 10.1056/NEJM200102153440707.CrossRefPubMed Klein I, Ojamaa K: Thyroid hormone and the cardiovascular system. N Engl J Med. 2001, 344 (7): 501-509. 10.1056/NEJM200102153440707.CrossRefPubMed
35.
go back to reference Bahouth SW: Thyroid hormones transcriptionally regulate the beta 1-adrenergic receptor gene in cultured ventricular myocytes. J Biol Chem. 1991, 266: 15863-15869.PubMed Bahouth SW: Thyroid hormones transcriptionally regulate the beta 1-adrenergic receptor gene in cultured ventricular myocytes. J Biol Chem. 1991, 266: 15863-15869.PubMed
36.
go back to reference Silva JE, Bianco SD: Thyroid-adrenergic interactions: physiological and clinical implications. Thyroid. 2008, 18: 157-165. 10.1089/thy.2007.0252.CrossRefPubMed Silva JE, Bianco SD: Thyroid-adrenergic interactions: physiological and clinical implications. Thyroid. 2008, 18: 157-165. 10.1089/thy.2007.0252.CrossRefPubMed
37.
go back to reference Dillmann WH: Cellular action of thyroid hormone on the heart. Thyroid. 2002, 12: 447-452. 10.1089/105072502760143809.CrossRefPubMed Dillmann WH: Cellular action of thyroid hormone on the heart. Thyroid. 2002, 12: 447-452. 10.1089/105072502760143809.CrossRefPubMed
38.
go back to reference Chen JL, Chiu HW, Tseng YJ, Chu WC: Hyperthyroidism is characterized by both increased sympathetic and decreased vagal modulation of heart rate: evidence from spectral analysis of heart rate variability. Clin Endocrinol. 2006, 64: 611-616. 10.1111/j.1365-2265.2006.02514.x.CrossRef Chen JL, Chiu HW, Tseng YJ, Chu WC: Hyperthyroidism is characterized by both increased sympathetic and decreased vagal modulation of heart rate: evidence from spectral analysis of heart rate variability. Clin Endocrinol. 2006, 64: 611-616. 10.1111/j.1365-2265.2006.02514.x.CrossRef
39.
go back to reference Bachman ES, Hampton TG, Dhillon H, Amende I, Wang J, Morgan JP, Hollenberg AN: The metabolic and cardiovascular effects of hyperthyroidism are largely independent of beta-adrenergic stimulation. Endocrinology. 2004, 145 (6): 2767-2774. 10.1210/en.2003-1670.CrossRefPubMed Bachman ES, Hampton TG, Dhillon H, Amende I, Wang J, Morgan JP, Hollenberg AN: The metabolic and cardiovascular effects of hyperthyroidism are largely independent of beta-adrenergic stimulation. Endocrinology. 2004, 145 (6): 2767-2774. 10.1210/en.2003-1670.CrossRefPubMed
40.
go back to reference Crozatier B, Su JB, Corsin A, Bouanani N-H: Species differences in myocardial beta-adrenergic receptor regulation in response to hyperthyroidism. Circ Res. 1991, 69: 1234-1243. 10.1161/01.RES.69.5.1234.CrossRefPubMed Crozatier B, Su JB, Corsin A, Bouanani N-H: Species differences in myocardial beta-adrenergic receptor regulation in response to hyperthyroidism. Circ Res. 1991, 69: 1234-1243. 10.1161/01.RES.69.5.1234.CrossRefPubMed
41.
go back to reference Cakir M: Takotsubo cardiomyopathy in thyrotoxicosis. Int J Cardiol. 2010, 145: 499-500. 10.1016/j.ijcard.2009.10.041.CrossRefPubMed Cakir M: Takotsubo cardiomyopathy in thyrotoxicosis. Int J Cardiol. 2010, 145: 499-500. 10.1016/j.ijcard.2009.10.041.CrossRefPubMed
42.
go back to reference Elesber AA, Prasad A, Lennon RJ, Wright RS, Lerman A, Rihal CS: Four-year recurrence rate and prognosis of the apical ballooning syndrome. J Am Coll Cardiol. 2007, 50 (5): 448-452. 10.1016/j.jacc.2007.03.050.CrossRefPubMed Elesber AA, Prasad A, Lennon RJ, Wright RS, Lerman A, Rihal CS: Four-year recurrence rate and prognosis of the apical ballooning syndrome. J Am Coll Cardiol. 2007, 50 (5): 448-452. 10.1016/j.jacc.2007.03.050.CrossRefPubMed
Metadata
Title
Takotsubo cardiomyopathy and transient thyrotoxicosis during combination therapy with interferon-alpha and ribavirin for chronic hepatitis C
Authors
Carmen Sorina Martin
Luminita Nicoleta Ionescu
Carmen Gabriela Barbu
Anca Elena Sirbu
Ioana Maria Lambrescu
Ioana Smarandita Lacau
Doina Ruxandra Dimulescu
Simona Vasilica Fica
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2014
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/1472-6823-14-10

Other articles of this Issue 1/2014

BMC Endocrine Disorders 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.